Abstract:Obstructive sleep apnea (OSA) is a highly prevalent chronic disease affecting nearly a billion people globally and increasing the risk of multi-organ morbidity and overall mortality. However, the mechanisms underlying such adverse outcomes remain incompletely delineated. Extracellular vesicles (exosomes) are secreted by most cells, are involved in both proximal and long-distance intercellular communication, and contribute toward homeostasis under physiological conditions. A multi-omics integrative assessment of plasma-derived exosomes from adult OSA patients prior to and after 1-year adherent CPAP treatment is lacking. We conducted multi-omic integrative assessments of plasma-derived exosomes from adult OSA patients prior to and following 1-year adherent CPAP treatment to identify potential specific disease candidates. Fasting morning plasma exosomes isolated from 12 adult patients with polysomnographically-diagnosed OSA were analyzed before and after 12 months of adherent CPAP therapy (mean ≥ 6 h/night) (OSAT). Exosomes were characterized by flow cytometry, transmission electron microscopy, and nanoparticle tracking analysis. Endothelial cell barrier integrity, wound healing, and tube formation were also performed. Multi-omics analysis for exosome cargos was integrated. Exosomes derived from OSAT improved endothelial permeability and dysfunction as well as significant improvement in tube formation compared with OSA. Multi-omic approaches for OSA circulating exosomes included lipidomic, proteomic, and small RNA (miRNAs) assessments. We found 30 differentially expressed proteins (DEPs), 72 lipids (DELs), and 13 miRNAs (DEMs). We found that the cholesterol metabolism (has04979) pathway is associated with lipid classes in OSA patients. Among the 12 subjects of OSA and OSAT, seven subjects had complete comprehensive exosome cargo information including lipids, proteins, and miRNAs. Multi-omic approaches identify potential signature biomarkers in plasma exosomes that are responsive to adherent OSA treatment. These differentially expressed molecules may also play a mechanistic role in OSA-induced morbidities and their reversibility. Our data suggest that a multi-omic integrative approach might be useful in understanding how exosomes function, their origin, and their potential clinical relevance, all of which merit future exploration in the context of relevant phenotypic variance. Developing an integrated molecular classification should lead to improved diagnostic classification, risk stratification, and patient management of OSA by assigning molecular disease-specific therapies.

PSGL-1: a novel immune checkpoint driving T-cell dysfunction in obstructive sleep apnea

Small Extracellular Vesicles Harboring PD-L1 in Obstructive Sleep Apnea

Improved levels of checkpoint molecule PD‐L1 on peripheral blood monocyte subsets in obstructive sleep apnea syndrome patients upon hypoglossal nerve stimulation

Intermittent Hypoxia Inhibits Anti-Tumor Immune Response Via Regulating PD-L1 Expression in Lung Cancer Cells and Tumor-Associated Macrophages.

Role of intestinal metabolites in the impact of obstructive sleep apnea on immunotherapy for lung cancer

[Immune Function of Myeloid-Derived Suppressor Cells and Its Mechanism in Obstructive Sleep Apnea Syndrome].

Obstructive sleep apnea-hypopnea syndrome immunological relationship

[CD69 Expression on T Cell Surface in Patients with Obstructive Sleep Apnea Hypopnea Syndrome].

Inflammation biomarkers in OSA, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease/OSA overlap syndrome

Heterogeneity of Melanoma Cell Responses to Sleep Apnea-Derived Plasma Exosomes and to Intermittent Hypoxia

Obstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption

Identification and Validation of Prognostic Factors of Lipid Metabolism in Obstructive Sleep Apnea

Obstructive sleep apnea and dyslipidemia: from animal models to clinical evidence

Association of CLDN molecules with sleep apnea hypopnea syndrome: new biomarker candidates

Intermittent Hypoxia Enhances the Tumor Programmed Death Ligand 1 Expression in a Mouse Model of Sleep Apnea.

Oxidative Stress and Inflammation Biomarker Expression in Obstructive Sleep Apnea Patients

Multi-Omics Analysis of Circulating Exosomes in Adherent Long-Term Treated OSA Patients

Molecular Pathology, Oxidative Stress, and Biomarkers in Obstructive Sleep Apnea

Association of dyslipidemia and hypoxemia in patients with obstructive sleep apnea hypopnea syndrome: a cross-sectional study

Obstructive Sleep Apnea Promotes Cancer Development and Progression: a Concise Review

CD40LG and GZMB were correlated with adipose tissue macrophage infiltration and involved in obstructive sleep apnea related metabolic dysregulation: Evidence from bioinformatics analysis